A comparison of once-daily and 8-hour gentamicin dosing in the treatment of postpartum endometritis

Obstetrics and Gynecology

Volumn 87, Issue 6, 1996, Pages 994-1000

  Del Priore, Giuseppe ^a   Jackson Stone, Marisa ^a   Shim, Elisabeth K ^a   Garfinkel, Jody ^a   Eichmann, Mary A ^a   Frederiksen, Marilynn C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; GENTAMICIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG COST; ENDOMETRITIS; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PUERPERAL INFECTION; RANDOMIZED CONTROLLED TRIAL;

EID: 0029952299     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00054-3     Document Type: Article

References (25)

1. Sweet RI, Ledger WJ. Puerperal infectious morbidity. A two-year review. Am J Obstet Gynecol 1973;117:1093-100.
2. Cunningham FG, Hauth JC, Strong JD, Kappus SS. Infectious morbidity following cesarean: Comparison of two treatment regimens. Obstet Gynecol 1978;52:656-61.
3. DiZerega G, Yonekura L, Roy S, Nakamura RM, Ledger WF. A comparison of clindamycin-gentamicin and penicillin-gentamicin in the treatment of post-cesarean endomyometritis. Am J Obstet Gynecol 1979;134:238-42.
4. Noone P, Parson TMC, Pattison JR, Slack RCB, Garfield-Davies D, Hughes K. Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. BMJ 1974;1:477-81.
5. Dahlgren JG, Anderson ET, Hewitt WL. Gentamicin blood levels: A guide to nephrotoxicity. Antimicrob Agents Chemother 1975;8: 58-62.
6. Goodman EL, Van Gelder J, Holmes R, Hull AR, Sanford JP. Prospective comparative study of variable dosage and variable frequency regimens for administration of gentamicin. Antimicrob Agents Chemother 1975;8:434-8.
7. Zaske DE, Cipolle RJ, Strate RG, Malo JW, Koszalka MF. Rapid gentamicin elimination in obstetric patients. Obstet Gynecol 1980; 56:559-64.
8. MacArthur RFD, Lolans V, Zar FA, Jackson GG. Biphasic, concentration-dependent and rate limited, concentration-independent bacterial killing by an aminoglycoside antibiotic. J Infect Dis 1984;150:778-9.
9. Jackson GG, Lolans VT, Daikos GL. The inductive role of ionic binding in the bactericidal and postexposure effects of aminoglycoside antibiotics with implications for dosing. J Infect Dis 1990; 162:408-13.
10. Vogelman B, Gudmundsson S, Turnidge J, Leggett J, Craig WA. In vivo postantibiotic effect in a thigh infection in neutropenic mice. J Infect Dis 1988;157:287-98.
11. Daikos GL, Jackson GG, Lolans VT, Livermore DM. Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. J Infect Dis 1990;162:414-20.
12. Daikos GL, Lolans VT, Jackson GG. First-exposure adaptive resistance to aminoglycosides in vivo with meaning for optimal clinical use. Antimicrob Agents Chemother 1991;35:117-23.
13. Barclay ML, Begg EJ, Chambers ST. Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrob Agents Chemother 1992;36:1951-7.
14. Bennett WM, Plamp CE, Gilbert DN, Parker RA, Parter GA. The influence of dosage regimen on experimental gentamicin nephrotoxicity: Dissociation of peak serum levels from renal function. J Infect Dis 1979;140:576-80.
15. Davis RR, Brummett RE, Bendrick TW, Himes DL. Dissociation of maximum concentration of kanamycin in plasma and perilymph from ototoxic effect. J Antimicrob Chemother 1984;14:291-302.
16. Prins JM, Büller HR, Kuijper Ej, Tange RA, Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993;341:335-9.
17. International Antimicrobial Therapy Cooperative Group. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 1993;119:584-93.
18. Briggs GC, Ambrose P, Nageotte MP. Gentamicin dosing in postpartum women with endometritis. Am J Obstet Gynecol 1989;160:309-13.
19. Sherrod SM, Rauch TM, Twist PA. Nursing care hour standards study. Part I - section A. Patient classification system model development. HCSD report no. 81-009. Springfield, Virginia: U.S. Department of Commerce National Technical Information Services, 1981.
20. Jolley ME, Stroupe SD, Wang CJ, Panas HN, Keegan CL, Schmidt RL, et al. Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma. Clin Chem 1981;27:1190-7.
21. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, 1982:27.
22. Atrash HK, Koonin LM, Lawson HW, Franks AI, Smith JC. Maternal mortality in the United States, 1979-1986. Obstet Gynecol 1990;76:1055-60.
23. Gardner DK, Schneider PJ. Gentamicin dosage requirements in postpartum patients. Clin Pharm 1984;3:416-8.
24. Munar MY, Lawson LA, Samuels P, Gibson GA. Gentamicin pharmacokinetics in postpartum women with endomyometritis. DICP 1991;25:1306-9.
25. Hutchin T, Cortopassi G. Proposed molecular and cellular mechanism for aminoglycoside ototoxicity. Antimicrob Agents Chemother 1994;38:2517-20.